Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia

Bhargavi Donepudi; Shikhar Agarwal; Lokendra Thakur

doi:10.1155/2022/8807957

Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia

Case Rep Crit Care. 2022 Oct 11:2022:8807957. doi: 10.1155/2022/8807957. eCollection 2022.

Authors

Bhargavi Donepudi¹, Shikhar Agarwal², Lokendra Thakur¹

Affiliations

¹ Department of Critical Care Medicine, Geisinger Medical Center, 100N Academy Ave, Danville, PA, USA.
² Department of Cardiology, Geisinger Medical Center, 100N Academy Ave, Danville, PA, USA.

Abstract

Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after the initiation of RDV that resolved after discontinuing RDV.

Publication types

Case Reports